National Institute for Health and Welfare, Helsinki, Finland.
J Affect Disord. 2011 Dec;135(1-3):221-30. doi: 10.1016/j.jad.2011.07.024. Epub 2011 Aug 26.
The need for treatment is, despite of its obvious usefulness, a scarcely used measure of effectiveness in psychotherapy trials. This study considers changes in the need for auxiliary psychiatric treatment after starting short- and long-term psychotherapy and psychoanalysis.
Altogether 326 psychiatric outpatients with mood or anxiety disorder were randomly assigned to solution-focused therapy (SFT), short-term psychodynamic psychotherapy (SPP), or long-term psychodynamic psychotherapy (LPP) while 41 self-selected patients were allocated to psychoanalysis (PA). The patients were followed for 5 years from start of treatment. Outcome measures were use of auxiliary psychotherapy, psychotropic medication, and hospitalization for mental reasons.
About 60% of the patients used auxiliary treatment during the follow-up. It was most common in the short-term therapy groups and its incidence was highest during the first year after the start of therapy. The average numbers of all therapy sessions among patients starting the therapy were 60, 70, 240, and 670 in SFT, SPP, LPP, and PA, respectively, whereas the corresponding average numbers of study therapy sessions alone were 10, 19, 232, and 646. Over 50% of the patients receiving short-term therapy received on average 4-6 times more therapy sessions than initially assigned.
Post-randomization withdrawal was uneven.
Auxiliary treatment is usual among patients receiving short- and long-term therapies, and apparently becomes common shortly after the start of treatment. Auxiliary treatment can be used as an outcome measure indicating the need for treatment, should be monitored clinically and considered when interpreting the results of effectiveness studies.
尽管治疗需求具有明显的实用性,但它在心理治疗试验中是一个很少被使用的有效性衡量标准。本研究考虑了在开始短期和长期心理治疗和精神分析后辅助精神治疗需求的变化。
共有 326 名患有情绪或焦虑障碍的精神科门诊患者被随机分配到解决焦点治疗(SFT)、短期心理动力学心理治疗(SPP)或长期心理动力学心理治疗(LPP)中,而 41 名自我选择的患者被分配到精神分析(PA)中。患者从治疗开始后随访 5 年。结局指标为辅助心理治疗、精神药物和因精神原因住院。
大约 60%的患者在随访期间使用了辅助治疗。它在短期治疗组中最为常见,其发生率在治疗开始后的第一年最高。开始治疗的患者的所有治疗次数的平均值分别为 SFT 中的 60、SPP 中的 70、LPP 中的 240 和 PA 中的 670,而单独接受治疗的研究治疗次数的相应平均值分别为 10、19、232 和 646。超过 50%的接受短期治疗的患者平均接受的治疗次数比最初分配的多 4-6 倍。
随机分组后退出不均衡。
短期和长期治疗的患者中通常会使用辅助治疗,并且在治疗开始后不久就明显变得常见。辅助治疗可以用作治疗需求的结果衡量标准,在临床上应进行监测,并在解释有效性研究结果时加以考虑。